The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Nils Wierup

Nils Wierup

Senior lecturer

Nils Wierup

G Protein-Coupled Receptor 39 Deficiency Is Associated with Pancreatic Islet Dysfunction

Author

  • Birgitte Holst
  • Kristoffer L. Egerod
  • Chunyu Jin
  • Pia Steen Petersen
  • Mette Viberg Ostergaard
  • Jacob Hald
  • A. M. Ejernaes Sprinkel
  • Joachim Storling
  • Thomas Mandrup-Poulsen
  • Jens J. Holst
  • Peter Thams
  • Cathrine Orskov
  • Nils Wierup
  • Frank Sundler
  • Ole D. Madsen
  • Thue W. Schwartz

Summary, in English

G protein-coupled receptor (GPR)-39 is a seven-transmembrane receptor expressed mainly in endocrine and metabolic tissues that acts as a Zn++ sensor signaling mainly through the G(q) and G(12/13) pathways. The expression of GPR39 is regulated by hepatocyte nuclear factor (HNF)-1 alpha and HNF-4 alpha, and in the present study, we addressed the importance of GPR39 for glucose homeostasis and pancreatic islets function. The expression and localization of GPR39 were characterized in the endocrine pancreas and pancreatic cell lines. Gpr39(-/-) mice were studied in vivo, especially in respect of glucose tolerance and insulin sensitivity, and in vitro in respect of islet architecture, gene expression, and insulin secretion. Gpr39 was down-regulated on differentiation of the pluripotent pancreatic cell line AR42J cells toward the exocrine phenotype but was along with Pdx-1 strongly up-regulated on differentiation toward the endocrine phenotype. Immunohistochemistry demonstrated that GRP39 is localized selectively in the insulin-storing cells of the pancreatic islets as well as in the duct cells of the exocrine pancreas. Gpr39(-/-) mice displayed normal insulin sensitivity but moderately impaired glucose tolerance both during oral and iv glucose tolerance tests, and Gpr39(-/-) mice had decreased plasma insulin response to oral glucose. Islet architecture was normal in the Gpr39 null mice, but expression of Pdx-1 and Hnf-1 alpha was reduced. Isolated, perifused islets from Gpr39 null mice secreted less insulin in response to glucose stimulation than islets from wild-type littermates. It is concluded that GPR39 is involved in the control of endocrine pancreatic function, and it is suggested that this receptor could be a novel potential target for the treatment of diabetes. (Endocrinology 150: 2577-2585, 2009)

Department/s

  • Department of Experimental Medical Science

Publishing year

2009

Language

English

Pages

2577-2585

Publication/Series

Endocrinology

Volume

150

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Endocrinology and Diabetes

Conference name

Keystone Meeting on Beta-Cell Function

Conference date

2008-04-06 - 2008-04-11

Status

Published

ISBN/ISSN/Other

  • ISSN: 0013-7227